G lutamate elicits cerebral arteriolar vasodilation in piglets via a multistep process, involving activation of neuronal N-methyl-D-aspartate (NMDA) receptors, stimulation of nitric oxide (NO) production by neuronal NO synthase, and actions of NO on vascular smooth muscle cells. [1] [2] [3] This sequence of events may represent an important mechanism coupling local blood flow to metabolism and neuronal activity.
NMDA-induced vasodilation is attenuated by hypoxia and ischemia/reperfusion (I/R) in a dose-and time-dependent manner. 4 -6 For example, 10 minutes of global ischemia followed by reperfusion reduces NMDA-induced vasodilation by Ϸ50%. However, arteriolar dilator responses to exogenously applied NO are intact, 5, 6 thereby implying that the attenuation of the vascular response to NMDA is due to See Editorial Comment, page 2718 effects of ischemia at the level of the neurons. Furthermore, results from other laboratories as well as our own indicate that dysfunction of the NMDA receptor rather than of general neuronal injury is the primary reason for attenuated arteriolar responsiveness to NMDA. 5, 7 The mechanisms involved in attenuated arteriolar dilation to NMDA are not known with certainty but appear to involve actions of reactive oxygen species (ROS), such as superoxide anion. Thus, pharmacological agents that prevent production of superoxide anion or that scavenge this radical prevent attenuation of NMDAinduced dilator responses. 4, 5, 8 In our laboratory, NMDA-induced vasodilation has been used as a sensitive bioassay to assess the functional integrity of the neuronal-vascular axis. For instance, we have shown that activation of ATP-sensitive potassium (K ATP ) channels with aprikalim for a short period immediately before combined hypoxic/ischemic stress preserves pial arteriolar dilation to NMDA. 6 Possible mechanisms of action of K ATP activation may be via hyperpolarization of neurons through plasmolemmal K ATP channels, which may result in (1) reduced glutamate release, (2) smaller increases in intracellular Ca 2ϩ levels during ischemia, or possibly (3) less ROS production during reperfusion. However, intracellular sites of action of K ϩ channel activators have not been considered previously.
Mitochondrial K ATP (mitoK ATP ) channels have been found in the inner membrane of mitochondria 9 and represent a pharmacologically distinct population of K ATP channels. 10 There is increasing evidence about the diverse functions of mitoK ATP channels in the regulation of mitochondrial matrix volume, ATP production, and Ca 2ϩ homeostasis in mitochondria, essential factors determining the outcome of ischemic stress on cellular function and survival. [11] [12] [13] [14] In fact, several K ϩ channel openers can mimic ischemic preconditioning (IPC) in the heart, 15 and mitoK ATP channels are certainly involved in mediating these effects. 16 -18 However, no study has investigated the possible beneficial role of mitoK ATP channel activation in vivo in the brain and the cerebral circulation.
In this study our purpose was to determine whether diazoxide, a selective mitoK ATP channel opener, would preserve the NMDA-induced arteriolar dilation 1 hour after 10 minutes of global cerebral ischemia. Additionally, we investigated whether 5-hydroxydecanoic acid (5-HD), a relatively selective inhibitor of mitoK ATP channels, would reduce the effect of diazoxide.
Materials and Methods

Animals
Newborn piglets of either sex (age, 1 to 7 days; body weight, 1 to 2 kg) were used. All procedures were approved by the Institutional Animal Care and Use Committee. The animals were anesthetized with sodium thiopental (30 to 40 mg/kg IP) followed by injection of ␣-chloralose (75 mg/kg IV). Supplemental doses of ␣-chloralose were given to maintain a stable level of anesthesia. The right femoral artery and vein were catheterized to record blood pressure and to administer drugs and fluids, respectively. The piglets were intubated via tracheotomy and artificially ventilated with room air. The ventilation rate (Ϸ20/min) and tidal volume (Ϸ20 mL) were adjusted to maintain arterial blood gas values and pH in the physiological range. Body temperature was maintained at 37°C to 38°C by a water-circulating heating pad. Body temperature, arterial pH, and blood gases were also in the normal ranges and did not vary significantly among different groups. For instance, in group 5, the values were as follows: body temperature, 37.9Ϯ0.2°C; pH, 7.51Ϯ0.03; PCO 2 , 33.3Ϯ1.9 mm Hg; and PO 2 , 97Ϯ4 mm Hg.
The head of the piglet was fixed in a stereotaxic frame. The scalp was incised and removed along with the connective tissue over the calvaria. A circular (19 mm in diameter) craniotomy was made in the left parietal bone. The dura was cut and reflected over the skull. A stainless steel cranial window with 3 needle ports was placed into the craniotomy, sealed with bone wax, and cemented with cyanoacrylate ester (Super Glue) and dental acrylic.
The closed window was filled with artificial cerebrospinal fluid (aCSF) warmed to 37°C and equilibrated with 6% O 2 and 6.5% CO 2 in balance N 2 to give pHϭ7.33, PCO 2 ϭ46 mm Hg, and PO 2 ϭ43 mm Hg. The aCSF consisted of the following (mmol/L): NaCl 132, KCl 2.9, CaCl 2 1.2, MgCl 2 1.4, NaHCO 3 24.6, urea 6.7, and glucose 3.7. Diameters of pial arterioles were measured with a microscope (Wild M36) equipped with a video camera (Panasonic) and a video micro scaler (IV-550, For-A-Co). After surgery, the cranial window was gently perfused with aCSF until a stable baseline was obtained. At the end of the experiments, the animals were killed while anesthetized with an intravenous bolus of KCl.
Cerebral Ischemia
To induce global cerebral ischemia, a 3-mm hole was made by an electric drill with a toothless bit, and the dura was exposed. A hollow brass bolt was inserted in the left frontal cranium rostral to the cranial window and secured in place with cyanoacrylate ester and dental acrylic. Cerebral ischemia was produced by infusion of aCSF to raise intracranial pressure above arterial pressure. Ischemia was verified by the cessation of blood flow in the observed vessels. Previously, we have shown using microspheres that cerebral blood flow is virtually zero in all brain areas examined during the ischemic period. 19 Venous blood was withdrawn as necessary to maintain mean arterial blood pressure near normal values. At the end of the ischemic period, the infusion tube was clamped, and the intracranial pressure returned to preischemic values. The heparinized blood was reinfused intravenously.
Experimental Design
After obtaining stable baseline arteriolar diameters, we examined the responses of cerebral arterioles to NMDA (10, 50, 100 mol/L, except in group 7). NMDA and all other drugs were dissolved in aCSF and administered topically through the injectable ports of the cranial window onto the brain surface with single application. Arteriolar diameters were measured continuously for 5 to 7 minutes for each dose of NMDA. Then the window was flushed with aCSF, and the arteriolar diameters returned to baseline values. Instrumented piglets (nϭ49) were then divided into 7 groups, as follows.
Group 1 (nϭ4)
To assess whether diazoxide may have direct effect on NMDAinduced vasodilation, in the first group the animals were treated with 10 mol/L diazoxide for 10 minutes but did not undergo ischemia. NMDA challenge was repeated 1 hour after treatment with diazoxide.
Group 2 (nϭ8)
To repeat our previous findings on attenuation of NMDA-induced vasodilation by I/R, in this group the piglets received vehicle (aCSF) and were exposed to 10 minutes of global cerebral ischemia followed by reperfusion. In all ischemia groups, NMDA-induced changes in pial arteriolar diameters were reexamined after the first hour of reperfusion. We have shown that attenuation of cerebral vasodilation to NMDA is greatest 1 hour after I/R (1 hour is also the shortest time after I/R at which the measurements are technically feasible).
Groups 3 to 5 (nϭ8, nϭ8, and nϭ12, Respectively)
To investigate the effect of diazoxide on preservation of NMDAinduced vasodilation, in these groups the piglets were pretreated with 1, 5, and 10 mol/L diazoxide, respectively, for 10 minutes before the initiation of 10 minutes of global cerebral ischemia. The diazoxide was removed by flushing the window with aCSF just before the initiation of ischemia.
Group 6 (nϭ5)
To investigate the inhibitory effect of 5-HD on K ATP channels activated by diazoxide, the piglets were pretreated with 100 mol/L 5-HD for 5 minutes, followed by coapplication of 100 mol/L 5-HD and 10 mol/L diazoxide for 10 minutes before 10 minutes of ischemia. The diazoxide and 5-HD were removed by flushing the window with aCSF just before the initiation of ischemia.
Group 7 (nϭ4)
To study the effect of 5-HD on the sarcolemmal K ATP channels and the vascular response to NMDA, we examined the cerebral arteriolar responses to the nonselective K ATP channel opener aprikalim (10 mol/L) followed by 100 mol/L NMDA. Then we coapplied 10 mol/L aprikalim and 100 mol/L 5-HD for 10 minutes. We repeated the NMDA challenge 1 hour after pretreatment with 5-HDϩaprikalim. Previously we have shown that aprikalim treatment does not affect the vascular response to NMDA. 6 Between each drug application we flushed the window several times with aCSF, until arteriolar diameters returned to baseline values.
Drugs
The drugs used in this study were NMDA (Sigma), diazoxide (Sigma), 5-HD (H135, Research Biochemicals International), and aprikalim (Rhone-Roulenc-Rohrer).
Statistical Analysis
Data are expressed as meanϮSEM. Pial arteriolar diameter data were analyzed with repeated-measures ANOVA, followed by pairwise comparisons using the Student-Newman-Keuls test when appropriate. Percent preservations of preischemic vasodilation data were analyzed with 1-tailed t test. P values of Ͻ0.05 were considered statistically significant.
Results
Arterial blood pressure was in the normal range and was not significantly different before and 1 hour after ischemia; for instance, in group 5 arterial pressure was 70Ϯ4 mm Hg before and 68Ϯ4 mm Hg after I/R (nϭ12).
Topical application of diazoxide did not affect pial vascular diameters significantly. Typically, there was only a transient dilation immediately on application of diazoxide. Percent changes from baseline diameters were as follows: group 3, no vasoactivity was observed; group 4, 2Ϯ1%; and group 5, 9Ϯ3%. Vascular diameters quickly returned to baseline values in 2 to 3 minutes, and none of these changes were significantly different from baseline values.
NMDA elicited dose-dependent pial arteriolar vasodilation (Figures 1 and 2) . In group 1, 10 mol/L diazoxide did not potentiate or attenuate vascular dilations to NMDA 1 hour after diazoxide treatment (Figure 1 ). Baseline arteriolar diameters were 100Ϯ2 m before and 100Ϯ6 m 1 hour after diazoxide treatment. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after diazoxide treatment) were 3Ϯ1% versus 4Ϯ1%, 28Ϯ7% versus 26Ϯ9%, and 50Ϯ8% versus 47Ϯ8%, respectively.
Global cerebral ischemia (10 minutes) followed by reperfusion significantly reduced pial arteriolar responses to NMDA (Figure 2) . In group 2, baseline arteriolar diameters were 100Ϯ3 m before and 103Ϯ4 m 1 hour after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after ischemia) were 6Ϯ2% versus 2Ϯ1%, 28Ϯ5% versus 9Ϯ3%, and 38Ϯ5% versus 16Ϯ4%, respectively. Thus, vascular dilations to 100 mol/L NMDA were diminished by Ϸ50% (Figure 3) .
Diazoxide exhibited a dose-dependent effect on preservation of NMDA-induced vasodilation after I/R. In group 3, decreases in pial arterial responsiveness to NMDA were similar to those observed in group 2 (Figures 2 and 3) . In group 3, baseline arteriolar diameters were 102Ϯ3 m before and 104Ϯ3 m 1 hour after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after ischemia) were 5Ϯ2% versus 3Ϯ1%, 20Ϯ7% versus 8Ϯ2%, and 38Ϯ5% versus 19Ϯ3%, respectively. In contrast, in groups 4 and 5 we found a dose-dependent preservation of pial vascular responses to NMDA (Figures 2 and 3 ). More specifically, in group 4, baseline arteriolar diameters were 95Ϯ3 m before and 95Ϯ4 m 1 hour after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after ischemia) were 4Ϯ0% versus 7Ϯ2%, 30Ϯ10% versus 23Ϯ6%, and 45Ϯ6% versus 37Ϯ3%, respectively. In group 5, baseline arteriolar diameters were 102Ϯ6 m before and 106Ϯ5 m 1 hour after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after ischemia) were 7Ϯ1% versus 6Ϯ2%, 28Ϯ5% versus 24Ϯ4%, and 36Ϯ5% versus 32Ϯ4%, respectively. Therefore, pretreatment with 10 mol/L diazoxide resulted in virtually full preservation of pial arteriolar responses to NMDA 1 hour after I/R compared with preischemic values.
Topical application of the K ATP channel antagonist 5-HD and coapplication of 5-HD with diazoxide did not alter pial arteriolar diameters. In addition, 5-HD treatment did not affect pial arteriolar responses to NMDA. In group 7, baseline arteriolar diameters were 105Ϯ9 m before and 103Ϯ7 m 1 hour after pretreatment with 5-HD. Percent changes in pial arteriolar diameter from baseline to 100 mol/L NMDA (before versus 1 hour after 5-HD treatment) were 52Ϯ3% versus 56Ϯ7%. However, pretreatment with 5-HD and diazoxide abolished the protection on NMDA-induced vasodilation achieved by diazoxide alone (Figures 2 and 3) . In group 6, baseline arteriolar diameters were 90Ϯ6 m before and 92Ϯ6 m 1 hour after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 mol/L NMDA (before versus 1 hour after ischemia) were 3Ϯ1% versus 0Ϯ0%, 40Ϯ12% versus 19Ϯ6%, and 61Ϯ7% versus 33Ϯ5%, respectively. Interestingly, coapplication of 5-HD with aprikalim did not block the vasodilation elicited by aprikalim. In group 7, pial baseline arteriolar diameters were 
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102Ϯ8 m before application of aprikalim alone and 101Ϯ7 m before coapplication of aprikalim and 5-HD. Percent changes in pial arteriolar diameter from baseline to 10 mol/L aprikalim were 65Ϯ6% versus 65Ϯ6% (aprikalim alone versus aprikalimϩ5-HD, respectively).
Discussion
The major finding of the present study is that the selective mitoK ATP channel opener diazoxide dose-dependently preserves NMDA-induced cerebral arteriolar vasodilation after I/R in piglets. Since NMDA-induced vasodilation is dependent on intact neuronal function, we present evidence for the first time showing an in vivo protective effect of diazoxide after I/R in the central nervous system. Previously, we found that the nonselective K ATP channel opener aprikalim protected NMDA-induced vasodilation after combined hypoxia-ischemia. 6 The protective effect of aprikalim was shown to be mediated by neuronal rather than vascular K ATP channels and was independent of the vasodilation elicited by aprikalim. Our present data confirm that the protective effect of pretreatment with K ϩ channel openers is independent of vasodilation accompanied by the administration of such drugs: diazoxide showed no significant vasoactivity but preserved NMDA-induced dilation. The beneficial effects of K ATP channel openers reducing injury by I/R have been most extensively studied in the heart. K ATP channels serve as the final common pathway in the event of IPC, a phenomenon in which short periods of ischemia protect the heart from subsequent exposure of a more prolonged period of ischemia. K ϩ channel openers mimic IPC, [15] [16] [17] [18] and the protection by IPC is blocked by K ATP channel inhibitors. 20 -22 The exact mechanism of this remarkable effect has not been elucidated.
The discovery of mitoK ATP channels added further complexity to the interpretation of experimental data from pharmacological interventions on these channels. Unfortunately, there are no absolutely selective pharmacological tools to assess the mitoK ATP channels in vivo. However, a consistent and unique feature of these channels is their remarkably selective sensitivity to opening by diazoxide. The mitoK ATP channel was found to be Ͼ2000-fold more sensitive to diazoxide than the sarcolemmal K ATP channel in bovine cardiac myocytes (K 1/2 was 0.4 mol/L for mitoK ATP channel versus 855 mol/L for sarcolemmal K ATP channel). In contrast, cromakalim was an equally potent opener of both mitochondrial and plasma membranes. 10 Subsequently, mitoK ATP channel selective concentrations (5 to 20 mol/L) of diazoxide have been demonstrated to improve functional recovery in isolated rat hearts after I/R in a manner similar to that of a nonselective K ATP channel opener, cromakalim. The cardioprotection by diazoxide was inhibited by K ATP channel inhibitors glibenclamide and 5-HD, confirming the effect of diazoxide via K ATP channels. 17 In a different study, in intact rabbit ventricular myocytes, diazoxide induced mitochondrial depolarization, demonstrated by flavoprotein fluorescence with a K 1/2 of 27 mol/L, but did not affect the simultaneously measured sarcolemmal K ATP channel current. 16 These findings and others in the literature (for recent review, see Reference 15) strongly indicate the involvement of mitoK ATP channels in the development of acute and perhaps delayed IPC in the heart.
In our present experiments we used topical diazoxide (1 to 10 mol/L) in the mitoK ATP channel-selective dose range. We did not test directly whether only mitoK ATP channels were activated by diazoxide, but fortunately a good indication of selective activation was the absence of significant vasodilation accompanied by application of diazoxide. The vasodilatory effect of K ϩ channel openers on cerebral arterioles was directly mediated by the sarcolemmal K ϩ channels. Administration of 5 to 10 mol/L diazoxide elicited only 2% to 9% arteriolar dilation, and the response was transient, ie, it did not last for Ͼ1 to 2 minutes. In contrast, we found that the nonselective K ATP channel opener aprikalim (10 mol/L) elicits Ϸ60% to 70% increases in vascular diameters, and the vasodilation does not wane. Moreover, the dose-dependent effect of diazoxide on preservation of the NMDA-induced vasodilation after I/R was inhibited by the selective K ATP channel antagonist 5-HD, and 5-HD was found to be selective for mitoK ATP channels, at least in some experimental designs. 16, 17, 23 Additionally, in our experimental model 5-HD did not inhibit the vasodilation induced by aprikalim, suggesting minor effects on plasmolemmal K ATP channel channels. These observations, together with those of the literature, lead us to conclude that the protective effect of diazoxide on neuronal-vascular function after I/R is probably mediated by activation of mitoK ATP channels.
The mechanism by which activation of mitoK ATP channels may lead to increased resistance to I/R remains to be clarified. In our experimental model, NMDA-induced vascular response is severely attenuated at 1 hour after I/R, and responsiveness gradually returns over the time course of 2 to 4 hours. 5, 24 The duration of global cerebral ischemia (10 minutes) used in the present study has been thought to cause only reversible mitochondrial alterations, ie, mitochondria have been shown to recover full function 1 to 2 hours after reperfusion. 25, 26 Thus, the attenuation of the NMDAmediated cerebral arteriolar response is not likely due to energy failure by inhibited mitochondrial function. This statement is further supported by our previous findings that kainate-induced vasodilation is resistant to ischemia in the same experimental model. 27 Additionally, neuronal NO synthase levels and activity are unchanged by I/R, and cerebral arterioles show normal responses to exogenous NO donors such as sodium nitroprusside after ischemia. 5, 6 Therefore, the primary target of I/R may be the NMDA receptor itself. The acute effect of ischemia on NMDA-induced pial arteriolar vasodilation has been amply demonstrated to be mediated by ROS (Figure 4) . Thus, NMDA-induced vascular response has been found to be preserved by ROS scavengers and inhibitors of cyclooxygenase (COX) activity, 4, 5, 8, 24 a major source of ROS after I/R. 28 Our recent observations on the preservation of neural function with K ϩ channel openers after hypoxia-ischemia were somewhat at odds with the general scheme of the pathological mechanism of the effect of I/R on NMDAinduced neuronal-vascular sequence. However, our present results may link the beneficial effect of K ϩ channel openers on preservation of NMDA-induced vasodilation to reducing oxidative stress on the neurons involved in this response. We speculate that activation of mitoK ATP channels by K ϩ channel openers may reduce mitochondrial ROS production.
Currently, the physiological role of mitoK ATP channels is still debated and mostly speculative. Briefly, mitoK ATP channels seem to control the activity of the electron transport chain via regulating mitochondrial matrix volume by regulated K ϩ uptake. The physiological patterns of activation and inhibition of these channels are largely unknown, but ironically the physiological role of ATP as a regulator is unlikely. 29 In isolated mitochondria, K ϩ channel openers induce slight swelling, partially dissipate the transmembrane potential (⌬⌿, negative inside), but increase the activity of electron transport chain and hence the chemical proton gradient (⌬pH, alkaline inside); thus, the total protonmotive hardly changes. 10 -14 However, the activity of numerous important transport mechanisms depends on either ⌬⌿ or ⌬pH. One such possibly crucial "metabolite" may be Ca 2ϩ . Mitochondria readily uptake Ca 2ϩ when intracellular levels increase above a so-called mitochondrial buffer concentration. Ca 2ϩ is transported through the mitochondrial inner membrane via the electrogenic Ca 2ϩ uniporter down its electrochemical gradient, and thus the rate of this transport is dependent on ⌬⌿. 30 Mitochondrial Ca 2ϩ overload substantially influences the recovery of mitochondrial function after ischemic stress: for example, increased mitochondrial Ca 2ϩ sequestration has ROS produced by mitochondria and COX seem to play a pivotal role in attenuating the NMDA-induced vasodilation. Thus, pretreatment with ROS scavengers, the COX inhibitor indomethacin, or the protein (including COX) synthesis inhibitor cycloheximide shortly before I/R results in preserved vascular responsiveness to NMDA. NMDA-induced dilation is also preserved by pretreatment with diazoxide, a selective mitoK ATP channel opener, and other K ϩ channel openers (KCO-s). Activation of mitoK ATP channels may reduce generation of ROS in reperfusion. Reduction in either COX-derived or mitochondrial ROS production may be sufficient to preserve the vascular response to NMDA after I/R. However, a potentiating interaction between these sources of ROS is conceivable but unknown.
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been demonstrated to increase production of ROS. 31, 32 Opening of mitoK ATP channels should decrease mitochondrial Ca 2ϩ uptake by decreasing ⌬⌿, and in fact K ϩ channel openers induce release of Ca 2ϩ from Ca 2ϩ -preloaded mitochondria in vitro. 11 In summary, we conclude that diazoxide in a mitoK ATP channel-selective range dose-dependently preserves neuronal function demonstrated by NMDA-induced arteriolar dilation after I/R. This acute effect of mitoK ATP channel openers may be mediated by decreasing mitochondrial ROS production in the immediate reperfusion. This effect may be important in the protective effect of other nonspecific K ϩ channel openers as well. Our findings may offer the development of new therapies to reduce neuronal injury after global hypoxic-ischemic stress in the newborn.
